Online citations, reference lists, and bibliographies.
Referencing for people who value simplicity, privacy, and speed.
Get Citationsy
← Back to Search

Hepatocyte Nuclear Factor‐4α Reverses Malignancy Of Hepatocellular Carcinoma Through Regulating MiR‐134 In The DLK1‐DIO3 Region

C. Yin, P. Wang, Wen-ping Xu, Yuan Yang, Qing Zhang, Bei-fang Ning, P. Zhang, W. Zhou, Wei-Fen Xie, Wan-Sheng Chen, X. Zhang
Published 2013 · Medicine, Biology

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Hepatocyte nuclear factor‐4α (HNF4α) is a dominant transcriptional regulator of hepatocyte differentiation and hepatocellular carcinogenesis. There is striking suppression of hepatocellular carcinoma (HCC) by HNF4α, although the mechanisms by which HNF4α reverses HCC malignancy are largely unknown. Herein, we demonstrate that HNF4α administration to HCC cells resulted in elevated levels of 28 mature microRNAs (miRNAs) from the miR‐379‐656 cluster, which is located in the delta‐like 1 homolog (DLK1) ‐iodothyronine deiodinase 3 (DIO3) locus on human chromosome 14q32. Consistent with the reduction of HNF4α, these miRNAs were down‐regulated in human HCC tissue. HNF4α regulated the transcription of the miR‐379‐656 cluster by directly binding to its response element in the DLK1‐DIO3 region. Interestingly, several miRNAs in this cluster inhibited proliferation and metastasis of HCC cells in vitro. As a representative miRNA in this cluster, miR‐134 exerted a dramatically suppressive effect on HCC malignancy by down‐regulating the oncoprotein, KRAS. Moreover, miR‐134 markedly diminished HCC tumorigenicity and displayed a significant antitumor effect in vivo. In addition, inhibition of endogenous miR‐134 partially reversed the suppressive effects of HNF4α on KRAS expression and HCC malignancy. Furthermore, a positive correlation between HNF4α and miR‐134 levels was observed during hepatocarcinogenesis in rats, and decreases in miR‐134 levels were significantly associated with the aggressive behavior of human HCCs. Conclusion: Our data highlight the importance of the miR‐379‐656 cluster in the inhibitory effect of HNF4α on HCC, and suggest that regulation of the HNF4α‐miRNA cascade may have beneficial effects in the treatment of HCC. (Hepatology 2013; 58:1964–1976)
This paper references
10.1186/1476-4598-5-29
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues
E. Bandrés (2006)
10.1016/j.bone.2011.10.012
Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma.
Venugopal Thayanithy (2012)
10.1016/j.cell.2011.10.043
An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis
M. Hatziapostolou (2011)
10.1053/J.GASTRO.2006.01.006
Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
D. Calvisi (2006)
10.1634/stemcells.2007-0295
MicroRNA‐134 Modulates the Differentiation of Mouse Embryonic Stem Cells, Where It Causes Post‐Transcriptional Attenuation of Nanog and LRH1
Y. Tay (2008)
10.1002/path.1928
Dysregulated expression of P1 and P2 promoter‐driven hepatocyte nuclear factor‐4α in the pathogenesis of human cancer
T. Tanaka (2006)
10.1136/gut.2008.174904
Hepatocyte nuclear factor 4α attenuates hepatic fibrosis in rats
H-Y Yue (2009)
10.1158/0008-5472.CAN-08-2129
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.
L. Chin (2008)
10.1074/jbc.M111.229831
DLK1-DIO3 Genomic Imprinted MicroRNA Cluster at 14q32.2 Defines a Stemlike Subtype of Hepatocellular Carcinoma Associated with Poor Survival
J. Luk (2011)
10.1002/hep.24280
The stable repression of mesenchymal program is required for hepatocyte identity: A novel role for hepatocyte nuclear factor 4α
L. Santangelo (2011)
10.1158/0008-5472.CAN-10-0824
Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
B. Ning (2010)
10.4161/epi.3.4.6550
Molecular mechanisms regulating phenotypic outcome in paternal and maternal uniparental disomy for chromosome 14
T. Ogata (2008)
10.1242/dev.045724
Activation of paternally expressed genes and perinatal death caused by deletion of the Gtl2 gene
Y. Zhou (2010)
10.1093/nar/gkm955
JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update
Jan Christian Bryne (2008)
10.1038/onc.2008.474
Role of miR-143 targeting KRAS in colorectal tumorigenesis
X. Chen (2009)
10.1038/nature07299
MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation
Y. Tay (2008)
10.1007/s00018-012-1080-8
The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis
L. Benetatos (2012)
10.1016/j.tig.2008.03.011
Genomic imprinting at the mammalian Dlk1-Dio3 domain.
S. T. da Rocha (2008)
10.1016/j.ajpath.2011.07.002
Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas.
Pornsuk Cheunsuchon (2011)
10.1002/hep.22510
Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor‐4α gene
C. Yin (2008)
10.1016/j.ejca.2010.02.043
Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
L. Guo (2010)
10.1002/path.2610
Localization‐ and mutation‐dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co‐expressed miRNAs located at 14q32.31
F. Haller (2010)
10.1074/jbc.M110.131995
Activation of the Imprinted Dlk1-Dio3 Region Correlates with Pluripotency Levels of Mouse Stem Cells*♦
L. Liu (2010)
10.1002/path.2802
Micro‐RNA signature of the epithelial–mesenchymal transition in endometrial carcinosarcoma
María Ángeles Castilla (2011)
10.1038/nature09017
Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells
M. Stadtfeld (2010)
10.1073/pnas.0801615105
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
L. Zhang (2008)
10.1158/0008-5472.CAN-09-4531
miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer.
S. Yu (2010)
10.1002/hep.23357
Integrated approach for the identification of human hepatocyte nuclear factor 4α target genes using protein binding microarrays
E. Bolotin (2010)
10.1186/1471-2164-9-346
Structural conservation versus functional divergence of maternally expressed microRNAs in the Dlk1/Gtl2 imprinting region
Martin Kircher (2008)
10.1073/PNAS.0600246103
Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver.
M. Battle (2006)
10.1002/hep.20155
Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors
Natalia L. Lazarevich (2004)
10.1016/S1470-2045(09)70343-2
Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis.
T. Ueda (2010)
10.1093/nar/gkj112
miRBase: microRNA sequences, targets and gene nomenclature
S. Griffiths-Jones (2006)
10.1158/1078-0432.CCR-07-1231
Altered MicroRNA Expression in Cervical Carcinomas
J. Lee (2008)
10.1038/emboj.2009.10
Mef2-mediated transcription of the miR379–410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels
R. Fiore (2009)
10.2144/000112010
Facile means for quantifying microRNA expression by real-time PCR.
Rui Shi (2005)
10.1073/pnas.0702177104
MicroRNA genes are frequently located near mouse cancer susceptibility loci
C. Sevignani (2007)
10.1016/J.YGENO.2005.09.018
High-resolution map and imprinting analysis of the Gtl2-Dnchc1 domain on mouse chromosome 12.
S. Tierling (2006)
10.1371/journal.pone.0038847
Deregulated miRNAs in Hereditary Breast Cancer Revealed a Role for miR-30c in Regulating KRAS Oncogene
M. Tanić (2012)
10.1371/journal.pone.0002141
Distinctive Patterns of MicroRNA Expression Associated with Karyotype in Acute Myeloid Leukaemia
A. Dixon-Mciver (2008)
10.1038/nature04367
A brain-specific microRNA regulates dendritic spine development
G. Schratt (2006)
10.1038/nm.2834
Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects
E. Jiménez-Mateos (2012)
10.1038/ng1175
Hepatocyte nuclear factor 4α controls the development of a hepatic epithelium and liver morphogenesis
F. Parviz (2003)
Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target Page 25 of 40 Hepatology Hepatology 26 genes using protein binding microarrays
E Bolotin (2010)
, where it causes post - transcriptional attenuation of Nanog and LRH 1
Y Tay (2008)
A SNP in a let7 microRNA complementary site in the KRAS 30 untranslated region increases non-small cell lung cancer risk
LJ Chin (2008)
Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. Hepatology 2008;48:1528-1539
C Yin (2008)
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in Page 24 of 40 Hepatology Hepatology 25 colorectal cancer and non-tumoral tissues
E Bandres (2006)
Molecular mechanisms regulating phenotypic outcome in paternal and maternal uniparental disomy for chromosome
T Ogata (2008)
Molecular mechanisms regulating phenotypic outcome in paternal and maternal uniparental dis - omy for chromosome 14
T Ogata (2008)
Hepatology Hepatology 27 MicroRNA-134 modulates the differentiation of mouse embryonic stem cells, where it causes post-transcriptional attenuation of Nanog and LRH1. Stem Cells 2008;26:17-29
YM Tay (2008)
Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats
HY Yue (2010)



This paper is referenced by
10.1371/journal.pone.0246022
In vivo effects of olive oil and trans-fatty acids on miR-134, miR-132, miR-124-1, miR-9-3 and mTORC1 gene expression in a DMBA-treated mouse model
Richard Molnar (2021)
10.20892/j.issn.2095-3941.2020.0131
Analysis of the HNF4A isoform-regulated transcriptome identifies CCL15 as a downstream target in gastric carcinogenesis.
Zhen Ni (2021)
10.1016/j.canlet.2019.12.046
Exosomes in Triple Negative Breast Cancer: Garbage Disposals or Trojan Horses?
Chia Yin Goh (2020)
10.1016/j.biopha.2020.109890
LncRNA MFI2-AS1 promotes HCC progression and metastasis by acting as a competing endogenous RNA of miR-134 to upregulate FOXM1 expression.
Y. Wei (2020)
10.1016/j.cellsig.2020.109720
Liver X receptor inhibits the growth of hepatocellular carcinoma cells via regulating HULC/miR-134-5p/FOXM1 axis.
Jintao He (2020)
10.7150/thno.32344
Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α
Bai-Nan Zheng (2019)
10.1136/gutjnl-2019-318830
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
Wen-ping Xu (2019)
10.1111/liv.14068
The concomitant loss of APC and HNF4α in adult hepatocytes does not contribute to hepatocarcinogenesis driven by β‐catenin activation
C. Sartor (2019)
10.1139/bcb-2018-0211
MicroRNA-134 Deactivates Hepatic Stellate Cells by Targeting TGF-β Activated Kinase 1-Binding Protein 1.
P. Wang (2019)
10.1155/2018/3274641
miR-142-5p in Bone Marrow-Derived Mesenchymal Stem Cells Promotes Osteoporosis Involving Targeting Adhesion Molecule VCAM-1 and Inhibiting Cell Migration
Zhaowei Teng (2018)
10.1002/ijc.31638
miR‐134 targets PDCD7 to reduce E‐cadherin expression and enhance oral cancer progression
Shih-Yuan Peng (2018)
10.1186/s12943-018-0813-1
The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1
C. Ding (2018)
10.1093/carcin/bgy022
MiR-134, epigenetically silenced in gliomas, could mitigate the malignant phenotype by targeting KRAS
Z. Wang (2018)
10.1158/0008-5472.CAN-17-3896
SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
Liang-zhi Wen (2018)
10.1128/MCB.00213-18
Induction of Hepatic Metabolic Functions by a Novel Variant of Hepatocyte Nuclear Factor 4γ
S. Sasaki (2018)
10.1002/jcp.26430
miR‐542‐3p prevents ovariectomy‐induced osteoporosis in rats via targeting SFRP1
Xiguang Zhang (2018)
10.1159/000492654
Mir-382 Promotes Differentiation of Rat Liver Progenitor Cell WB-F344 by Targeting Ezh2
Yongxia Zheng (2018)
10.1089/GTMB.2017.0179
Curcumin Suppresses In Vitro Proliferation and Invasion of Human Prostate Cancer Stem Cells by Modulating DLK1-DIO3 Imprinted Gene Cluster MicroRNAs
ZhangHu (2017)
10.1038/emm.2016.177
Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma
B. Zhang (2017)
10.1038/onc.2016.332
miR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop
L. Shi (2017)
10.1093/toxsci/kfx104
Xenobiotic CAR Activators Induce Dlk1-Dio3 Locus Noncoding RNA Expression in Mouse Liver
Lucie Pouché (2017)
10.3892/or.2017.5350
miR-134 suppresses the migration and invasion of non‑small cell lung cancer by targeting ITGB1.
Q. Qin (2017)
10.1016/j.omtn.2016.11.003
miR-134: A Human Cancer Suppressor?
Jingyu Pan (2017)
10.3892/or.2017.6046
Immature colon carcinoma transcript-1 promotes cell growth of hepatocellular carcinoma via facilitating cell cycle progression and apoptosis resistance.
Weiping Chang (2017)
10.4254/wjh.v9.i4.191
Regulation of hepatic microRNA expression by hepatocyte nuclear factor 4 alpha
H. Lu (2017)
10.2217/nnm-2016-0408
Therapeutic PEG-ceramide nanomicelles synergize with salinomycin to target both liver cancer cells and cancer stem cells.
Meiping Wang (2017)
10.1074/jbc.M117.785592
An HNF4α–microRNA-194/192 signaling axis maintains hepatic cell function
Aoi Morimoto (2017)
10.7150/jca.17640
Protein Regulator of Cytokinesis PRC1 Confers Chemoresistance and Predicts an Unfavorable Postoperative Survival of Hepatocellular Carcinoma Patients
Y. Wang (2017)
10.3892/ol.2017.5644
MicroRNA-134 targets KRAS to suppress breast cancer cell proliferation, migration and invasion.
Xiaomei Su (2017)
10.1016/j.gene.2016.12.030
MicroRNA-134-3p is a novel potential inhibitor of human ovarian cancer stem cells by targeting RAB27A.
C. Chang (2017)
10.18632/oncotarget.8478
Apoptosis signal-regulating kinase 1 mediates the inhibitory effect of hepatocyte nuclear factor-4α on hepatocellular carcinoma
Cai-Feng Jiang (2016)
10.1111/hepr.12618
miRNA‐548p suppresses hepatitis B virus X protein associated hepatocellular carcinoma by downregulating oncoprotein hepatitis B x‐interacting protein
Xiumei Hu (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar